BCPC BALCHEM CORP
Q3 2025 10-Q
BALCHEM CORP (BCPC) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 21, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Risk Factors
- • New anti-dumping risk: EU provisional duties 95.4%-120.8% on Chinese choline chloride imports, effective July 1, 2025, final duties proposed 90.0%-115.9%
- • Regulatory risk update: EU anti-dumping measures on choline chloride may restrict market access, investigation initiated October 2024 with final measures expected by end 2025
Quarterly Financial SummaryXBRL
Revenue
$268M
▲ +11.5% YoY▲ +4.7% QoQ
Net Income
$40M
▲ +19.1% YoY▲ +5.3% QoQ
Gross Margin
35.7%
▲ +10bp YoY▼ -77bp QoQ
Operating Margin
20.4%
▲ +40bp YoY▲ +26bp QoQ
Net Margin
15.1%
▲ +96bp YoY▲ +7bp QoQ
ROE
3.1%
Total Assets
$1.7B
EPS (Diluted)
$1.24
▲ +20.4% YoY▲ +6.0% QoQ
Operating Cash Flow
$66M
▲ +27.8% YoY▲ +38.8% QoQ
Source: XBRL data from BALCHEM CORP Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on BALCHEM CORP
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.